Marianne P. Allen

Array ( [id] => 7728633 [patent_doc_number] => 08101198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Osteogenic enhancer composition' [patent_app_type] => utility [patent_app_number] => 12/374475 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 6993 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101198.pdf [firstpage_image] =>[orig_patent_app_number] => 12374475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867986 [patent_doc_number] => 20080147045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Use of VEGF-C or VEGF-D in Reconstructive Surgery' [patent_app_type] => utility [patent_app_number] => 11/782225 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28451 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20080147045.pdf [firstpage_image] =>[orig_patent_app_number] => 11782225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682733 [patent_doc_number] => 20080248959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES' [patent_app_type] => utility [patent_app_number] => 11/781896 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 77838 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248959.pdf [firstpage_image] =>[orig_patent_app_number] => 11781896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910215 [patent_doc_number] => 20080020982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Methods and compositions for treatment of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/880401 [patent_app_country] => US [patent_app_date] => 2007-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19241 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020982.pdf [firstpage_image] =>[orig_patent_app_number] => 11880401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374689 [patent_doc_number] => 20090312250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'EPIDERMAL GROWTH FACTOR INCREASING INSULIN SECRETION AND LOWERING BLOOD GLUCOSE' [patent_app_type] => utility [patent_app_number] => 12/373691 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7944 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312250.pdf [firstpage_image] =>[orig_patent_app_number] => 12373691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927386 [patent_doc_number] => 20080166749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Fluorescent Protein Sensors of Post-Translational Modifications' [patent_app_type] => utility [patent_app_number] => 11/775067 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20755 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166749.pdf [firstpage_image] =>[orig_patent_app_number] => 11775067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210009 [patent_doc_number] => 20070248593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => '32 Human Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 11/767824 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55835 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248593.pdf [firstpage_image] =>[orig_patent_app_number] => 11767824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566730 [patent_doc_number] => 20100234290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Stabilized Insulin-like Growth Factor Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/304068 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12546 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234290.pdf [firstpage_image] =>[orig_patent_app_number] => 12304068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652137 [patent_doc_number] => 20080039393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Metal-binding therapeutic peptides' [patent_app_type] => utility [patent_app_number] => 11/809527 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 25662 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039393.pdf [firstpage_image] =>[orig_patent_app_number] => 11809527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379310 [patent_doc_number] => 20090191149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/300712 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3891 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191149.pdf [firstpage_image] =>[orig_patent_app_number] => 12300712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469846 [patent_doc_number] => 08299024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Methods to restore glycemic control' [patent_app_type] => utility [patent_app_number] => 12/298933 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16527 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12298933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257636 [patent_doc_number] => 08207116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Remedies for ischemia' [patent_app_type] => utility [patent_app_number] => 12/296584 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26363 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12296584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624311 [patent_doc_number] => 08003607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'HGF precursor protein variant and active protein thereof' [patent_app_type] => utility [patent_app_number] => 12/226448 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11153 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003607.pdf [firstpage_image] =>[orig_patent_app_number] => 12226448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159436 [patent_doc_number] => 20070172480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE' [patent_app_type] => utility [patent_app_number] => 11/689392 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5228 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172480.pdf [firstpage_image] =>[orig_patent_app_number] => 11689392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159849 [patent_doc_number] => 20070172893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE' [patent_app_type] => utility [patent_app_number] => 11/689385 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5236 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172893.pdf [firstpage_image] =>[orig_patent_app_number] => 11689385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824998 [patent_doc_number] => 20080124346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Metal-binding therapeutic peptides' [patent_app_type] => utility [patent_app_number] => 11/725672 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 24814 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124346.pdf [firstpage_image] =>[orig_patent_app_number] => 11725672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442297 [patent_doc_number] => 07928072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Multimeric constructs' [patent_app_type] => utility [patent_app_number] => 11/716794 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 9717 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928072.pdf [firstpage_image] =>[orig_patent_app_number] => 11716794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539703 [patent_doc_number] => 20090221508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/278990 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5039 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221508.pdf [firstpage_image] =>[orig_patent_app_number] => 12278990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4441548 [patent_doc_number] => 07927871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers' [patent_app_type] => utility [patent_app_number] => 11/669080 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 16375 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927871.pdf [firstpage_image] =>[orig_patent_app_number] => 11669080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069062 [patent_doc_number] => 20070190163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Technology for preparation of macromolecular microspheres' [patent_app_type] => utility [patent_app_number] => 11/657812 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36543 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190163.pdf [firstpage_image] =>[orig_patent_app_number] => 11657812 [rel_patent_id] =>[rel_patent_doc_number] =>)